Edwards Lifesciences Corporatio Price Today
Edwards Lifesciences Corporatio
EW
Healthcare
$48.84B
💰
Market Cap
33.4
💸
Price to Earnings
$2.4
🎉
EPS
+81
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
16 |
Strong Buy |
7 |
Hold |
14 |
Sell |
0 |
Strong Sell |
1 |
EW Price Forecast Target
79.5 👉 110.0 +38%
EW EPS Forecast
2.4 👉 2.9 +21%
Financials
Profit Margin
25 %
Revenue Growth
11.4 %
Dividend
$ 0
Held Percent
0.9% - Insiders
85.6% - Institutions
13.5% - Public
Major Fund Holders
-
💰 Blackrock Inc. $4.1B
-
💰 Vanguard Group Inc $4.1B
-
💰 State Street Corporation $2.1B
-
💰 Capital International Investors $2.0B
-
💰 Alliancebernstein L.P. $1.6B
Stock Ideas
Michael Burry Portfolio
Michael Burry, the renowned value investor and founder of Scion Asset Management, gained limited recognition until his story was documented in Michael Lewis' bestseller 'The Big Short.' Despite predicting the subprime mortgage crisis, Scion's AUM fe…
Christopher Hohn Portfolio
Christopher Hohn is a British hedge fund manager and philanthropist. He founded The Children's Investment Fund Management in 2003, one of Europe's largest hedge funds. Known for his activist investment approach, Hohn targets undervalued companies wi…
Daniel Loeb Portfolio
Daniel Loeb is an American billionaire businessman and founder/CEO of Third Point LLC, a global investment firm managing over $12 billion in assets through long/short equity investments and activism. As one of the world's most successful hedge fund…
Andreas Halvorsen Portfolio
Andreas Halvorsen is a Norwegian billionaire investor, hedge fund manager, and the founder of Viking Global Investors, a large hedge fund with over $50 billion in assets under management. He is known for his long-term, value-oriented investment appr…📮FAQ
Some Frequently Asked Questions.
The Edwards Lifesciences Corporatio industry is Medical Devices
The Edwards Lifesciences Corporatio sector is Healthcare
The Edwards Lifesciences Corporatio forecasted predicted Price to Earnings PE ratio is 27.6
The Edwards Lifesciences Corporatio Price to Earnings PE ratio is 33.4
The Market Capitalization of Edwards Lifesciences Corporatio is $48.84B
There are total of 602317391 float shares with 85.6% held by Institutions and 0.9% held by insiders
The MEdwards Lifesciences Corporatio forecasted Earnings per Share EPS is $2.9
The Edwards Lifesciences Corporatio Earnings per Share EPS is 2.4
The Edwards Lifesciences Corporatio company has $4303600000 gross profits with 25 profit margins
The Edwards Lifesciences Corporatio Earnings Growth is -0.231% with -0.244% quarterly earnings growth
The Edwards Lifesciences Corporatio Revenue is $5657099776 with 0.114 revenue growth
The price target for Edwards Lifesciences Corporatio stock is $110.0 for the high target and $75.0 for the low target
The consensus analyst recommendations for Edwards Lifesciences Corporatio is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Edwards Lifesciences Corporatio is Buy, with the following breakdown:
- Buy: 16
- Strong Buy: 7
- Hold: 14
- Sell: 0
- Strong Sell: 1
The Beta of Edwards Lifesciences Corporatio is 1.0
The dividend of Edwards Lifesciences Corporatio is $0
The dividend yield of Edwards Lifesciences Corporatio is 0%
The biggest institutional and mutual fund holders of Edwards Lifesciences Corporatio stock are
- Blackrock Inc.
- Vanguard Group Inc
- State Street Corporation
- Capital International Investors
The Edwards Lifesciences Corporatio ESG Score is 81, with the following breakdown:
- E: 2.86
- S: 8.85
- G: 7.63